Literature DB >> 11936710

Quality and impact of problem-oriented drug information: a method to change clinical practice among physicians?

Jan Schjøtt1, Erik Pomp, Ane Gedde-Dahl.   

Abstract

OBJECTIVES: Problem-oriented drug information is characterised by health professionals actively seeking drug information through various sources. In this study our objective was to determine the quality and impact of problem-oriented drug information among physicians.
METHODS: Evaluation forms accompanying 163 written answers to physicians from a drug information centre were used to examine the quality and impact of problem-oriented drug information during the period December 1996 to June 1998. Physicians were asked whether the preliminary telephone answer was useful and, furthermore, whether the written answer was fast enough, relevant, adequately comprehensive and had valuable references. Physicians were also asked whether the answer had caused any change in their clinical practice. If yes, they were then asked to describe the actual changes.
RESULTS: Of 163 evaluation forms, 117 (72%) were returned by physicians. Eighty-six physicians received a preliminary telephone answer and 83 (97%) stated that this was useful. Among the physicians, 92 (79%) found that the answer was fast enough, relevant, adequately comprehensive and with valuable references, while 19 (16%) found that the answer satisfied three of these four quality criteria. Seventy-one evaluation forms stated that the answer had caused a change in clinical practice. Sixty-eight (96%) of these contained a description of the change. Thirty-five evaluation forms that stated that the answers did not cause any change in clinical practice showed the same quality score as for the total group. Thus, 28 (80%) of these satisfied four and 5 (14%) satisfied three of the quality criteria. Improved routines for and control of ongoing pharmacotherapy was the most common change in clinical practice reported by physicians.
CONCLUSION: The results show that, in general, physicians found problem-oriented drug information to be of high quality, and that it had an impact on their clinical practice. Problem-oriented drug information could be a method to change clinical practice among physicians.

Mesh:

Year:  2002        PMID: 11936710     DOI: 10.1007/s00228-001-0386-5

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Drug use in pregnancy--physicians' evaluation of quality and clinical impact of drug information centres.

Authors:  Sofia Kristina Frost Widnes; Jan Schjøtt
Journal:  Eur J Clin Pharmacol       Date:  2008-12-04       Impact factor: 2.953

2.  Advice on drug safety in pregnancy: are there differences between commonly used sources of information?

Authors:  Sofia K Frost Widnes; Jan Schjøtt
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  Norwegian drug information centres strongly promote person-centred and personalised medicine: a brief report on the achievements and strategy.

Authors:  Jan Schjøtt
Journal:  EPMA J       Date:  2019-04-30       Impact factor: 6.543

4.  Which factors predict the time spent answering queries to a drug information centre?

Authors:  Linda A Reppe; Olav Spigset; Jan Schjøtt
Journal:  Pharm World Sci       Date:  2010-10-05

Review 5.  [Drug information services for physicians and patients. Acceptance and benefits].

Authors:  A Fuchs; U Winkler; U Maywald; W Kirch
Journal:  Internist (Berl)       Date:  2007-09       Impact factor: 0.743

6.  Problem-oriented drug information: physicians' expectations and impact on clinical practice.

Authors:  U Hedegaard; P Damkier
Journal:  Eur J Clin Pharmacol       Date:  2009-01-10       Impact factor: 2.953

7.  A question-answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study.

Authors:  Jan Schjøtt; Linda A Reppe; Pål-Didrik H Roland; Tone Westergren
Journal:  BMJ Open       Date:  2012-03-15       Impact factor: 2.692

8.  Joint medicine-information and pharmacovigilance services could improve detection and communication about drug-safety problems.

Authors:  Jan Schjøtt; Jenny Bergman
Journal:  Drug Healthc Patient Saf       Date:  2014-07-01

9.  Questions about complementary and alternative medicine to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive pilot study.

Authors:  Jan Schjøtt; Hilde Erdal
Journal:  BMC Complement Altern Med       Date:  2014-02-14       Impact factor: 3.659

10.  Factors associated with time consumption when answering drug-related queries to Scandinavian drug information centres: a multi-centre study.

Authors:  Linda Amundstuen Reppe; Olav Spigset; Ylva Böttiger; Hanne Rolighed Christensen; Jens Peter Kampmann; Per Damkier; Stian Lydersen; Jan Schjøtt
Journal:  Eur J Clin Pharmacol       Date:  2014-09-12       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.